Every material Form 8-K Research Solutions, Inc. has filed with the SEC since May 14, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Research Solutions reported fiscal 2026 net income of $2.8 million, or $0.09 per diluted share, up from $1.3 million, or $0.04, a year earlier, while total revenue fell to $48.3 million from $49.1 million. Fourth-quarter revenue of $12.1 million and net income of $666,000 were both below the prior-year quarter, which included a $1.1 million favorable Scite earnout adjustment, so shareholders see a mixed picture of annual profit growth alongside shrinking sales.
Fiscal 2026 net income was $2.8 million, or $0.09 per diluted share, versus $1.3 million, or $0.04, in fiscal 2025.
Fiscal 2026 total revenue was $48.3 million versus $49.1 million; transaction revenue fell to $27.5 million from $30.1 million.
Fourth-quarter net income was $666,000, or $0.02 per diluted share, versus $2.4 million, which included a $1.1 million Scite earnout adjustment.
B2B ARR rose 14.1% to $16.2 million, and total ARR rose 7.8% to $22.5 million as of June 30, 2026.
Research Solutions appointed Dave Kutil, who had been interim CFO since December 10, 2025, as Chief Financial Officer under an employment agreement with a $275,000 base salary and bonus of up to $55,000. The company also terminated Chief Revenue Officer Sefton Cohen on July 31, 2026, and the filing gives no reason for the departure.
Kutil appointed CFO on July 28, 2026; previously Global Controller from March 2023 to December 2025
Base salary of $275,000 with bonus eligibility of up to $55,000 if performance milestones are met
Sefton Cohen terminated as Chief Revenue Officer on July 31, 2026
Research Solutions reported fiscal third-quarter 2026 results for the quarter ended March 31, 2026. Total revenue fell 4.3% to $12.1 million, while net income rose to $860,000, or $0.03 per diluted share, from $216,000, or $0.01 a year earlier, and annual recurring revenue grew 8.5% to $22.1 million.
Total revenue was $12.1 million, down from $12.7 million, as lower transaction revenue more than offset platform growth.
Net income was $860,000, or $0.03 per diluted share, versus $216,000, or $0.01, in the prior-year quarter.
Annual recurring revenue rose 8.5% to $22.1 million; operating cash flow was $1.0 million, down from $2.9 million.
Adjusted EBITDA rose 14% to $1.6 million; gross margin improved 220 basis points to 51.7%.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Research Solutions, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →